Systematic Reviews
Copyright ©The Author(s) 2015.
World J Clin Cases. Sep 16, 2015; 3(9): 807-822
Published online Sep 16, 2015. doi: 10.12998/wjcc.v3.i9.807
Table 1 Studies on the role of the rs738409PNPLA3 polymorphisms in hepatitis C virus chronic infection
Ref.No. ofCountryType of studyLiver diseaseOutcome (GG vs GC + CC)
patientsSteatosisSevere steatosisCirrhosisSVRHCC
Cai et al[98]626SwitzerlandCross-sectionalChronic liver diseaseOR = 1.880 (95%CI: 1.571-2.250)1OR = 1.578 (95%CI: 1.331-1.870)12
Clark et al[101]972United StatesCross-sectionalChronic liver diseaseOR = 1.62 (95%CI: 1.22-2.14)3OR = 1.78 (95%CI: 1.40-2.27)34No association (P = 0.294)3
Dunn et al[103]101United StatesCohortLiver transplantation recipients and donorsHR = 2.53, (95%CI: 1.28-5.02)56
Guyot et al[105]253FranceCohortCirrhosisNo association (P = 0.5)7No association (P = 0.5)
Nakamura et al[102]260JapanCross-sectional37 Cirrhosis 223 Chronic hepatitisNo association (P = 0.935)8No association (P = 0.876)8
Nischalke et al[104]162GermanyCase-controlCirrhosisNo association (P = 0.386)
Trépo et al[96]537Belgium, Germany, FranceCross-sectionalChronic liver diseaseOR = 2.84 (95%CI: 1.22-6.60)2OR = 2.43 (95%CI: 1.24-4.78)9
Valenti et al[97]819ItalyCross-sectional/case-control548 Chronic hepatitis 215 Cirrhosis 56 HCCOR = 1.90 (95%CI: 1.39-2.73)OR = 2.09 (95%CI: 1.62-2.67)4OR = 1.47 (95%CI: 1.15-1.87)OR = 0.63 (95%CI: 0.44-0.86)10OR = 2.16 (95%CI: 1.33-3.59)11
Zampino et al[99]166ItalyCross-sectionalChronic hepatitisMean steatosis score GG: 1.94 ± 1.6, CG: 1.25 ± 1.2, CC: 1 ± 1.1, P < 0.05